(Q61917643)

English

Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

scientific article published on 15 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

phase I clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Katherine K Matthay

15

object named as

Katherine K Matthay

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

11

object named as

John M Maris

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Steven G DuBois

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Susan Groshen

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Randall Hawkins

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Fariba Goodarzian

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Hiroyuki Shimada

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Greg Yanik

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Michael Tagen

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Clinton Stewart

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Yael P Mosse

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Denice Tsao-Wei

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Araz Marachelian

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Judith G Villablanca

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

0 references

publication date

15 March 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

2679-2686

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitization with chemotherapeutic agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal iodine-131-meta-iodobenzylguanidine activity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase I-targeting drugs as radiation sensitizers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of carboxylate and lactone forms of irinotecan and three metabolites in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics: to test or not to test, that is the question

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecins: a review of their development and schedules of administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing irinotecan-associated diarrhea in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22421195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-11-3201

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421195%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61917643&oldid=2186462279"